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Influenza B viruses circulated in Taiwan 511specificity, were found to be subject to positive selection. No drug-resistant sites were noticed
in the NA sequences. In addition, we identified several cases of NA reassortment with an over-
all incidence rate of 6% for the investigated Taiwan strains.
Conclusion: We highlighted the interplay between mutations in the glycosylation sites and
epitope during HA evolution. These are crucial molecular signatures to be monitored for influ-
enza B epidemics in the future.
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The influenza B virus belongs to the Orthomyxoviridae
family, and contains eight negative-sense, single-stranded
segmented genomes. Unlike the influenza A virus, which
can infect a wide range of hosts and result in distinct
species-associated genomic characteristics,1 influenza B
virus is only known to infect humans and seals. These
viruses are classified into two antigenically distinct line-
ages, according to the phylogenetic relationship of the
hemagglutinin (HA) gene: the Victoria lineage B/Victoria/
2/87 and the Yamagata lineage B/Yamagata/16/88.2e4 The
HA protein plays an active role in receptor binding and
membrane fusion, thus facilitating viral entry.5 The evo-
lution of the influenza B virus has been studied in molecular
analyses of the other surface glycoprotein: the neuramin-
idase (NA) gene. NA plays a vital role in the late stages of
viral replication, cleaving the a-2,3 and a-2,6 glycosidic
linkages at the terminal end of the functional group of
sialic acids in the glycoprotein molecules, thus enabling
successful release of virus.6 Both proteins are present as
structural epitopes, which are recognized by the host im-
mune system.7 Both proteins have been subjected to
considerable antigenic drift, resulting in antigenic variation
from one epidemic or influenza season to the next. More-
over, the reassortment within different lineages, as well as
different insertions and deletions, has increased the ge-
netic diversity of influenza B viruses.2,3,8
High genome diversity and the multiplicity of genotypes
are caused by viruses cocirculating for a particular period
and in a particular region.8e11 The evolution and antigenic
drift of influenza B viruses are reportedly slower than those
of influenza A viruses, but faster than those of influenza C
viruses.8 However, human clinical reports have suggested
that influenza B viral infections may induce clinical and
inflammatory responses that are more severe than influ-
enza A viral infections.12,13 One study reported that do-
mestic pigs are particularly susceptible to influenza B virus
infections, indicating that swine are natural reservoirs of
influenza B viruses.14
An influenza B outbreak occurred in Taiwan during the
2004/2005 season. The cocirculation of viruses of both the
Victoria and Yamagata lineages resulted in reassorted Vic-
toria viruses, in which some viral genes were found to be
Victoria-like (one HA and two polymerase genes PB1 and
PB2), and others were observed to be Yamagata-like.15 Only
Victoria viruses were detected during the 2006/2007
epidemic, and their HA genes were similar to those of the
2004/2005 outbreak.16 Although the NA genes of the 2006/2007 Victoria viruses were also determined to be Yamagata-
like, they showed more distinct substitutions compared
with the 2004/2005 viruses.16 A large-scale survey by the
Taiwan Centers for Disease Control reported the continual
emergence of novel influenza B genotypes from 2004 to
2012, with some genotypes found to be dominant over
influenza A viruses (2004/2005, 2006/2007, and 2011/
2012).17 Dominance between the two lineages (Victoria or
Yamagata) shifted between seasons; some epidemic strains
had lineage mismatch with the trivalent vaccines recom-
mended by the World Health Organization (WHO). Even
with the vaccines recommended by the WHO, which
matched either the Victoria- or Yamagata-like lineage of
the influenza B viruses encountered in Taiwan, some amino
acid substitutions on the HA can jeopardize the antigenicity
and thus compromise vaccine effectiveness.
In this study, we analyzed all available Taiwanese
influenza B HA and NA sequences from public domain da-
tabases between 2003 and 2014, including newly deter-
mined full-length HA and NA genes of 33 influenza B viruses
detected in Linkou Chang Gung Memorial Hospital (CGMH).
We explored the phylogenetic relationship of these se-
quences by focusing on the distinct evolutionary patterns
between the Yamagata and Victoria lineages. The cocircu-
lation of viruses from both lineages in Taiwan and the
compatibility of the vaccine strains with the virus were
examined. Finally, a comparative analysis of the HA and NA
sequences were performed, revealing the genetic reas-
sortment of influenza B viruses in Taiwan.
Materials and methods
Viruses and cell lines
The CGMH collected 33 laboratory-confirmed influenza B
virus samples during influenza epidemics in Taiwan be-
tween 2004 and 2014. MadineDarby canine kidney cell lines
(ATCC CCL-34, American Type Culture Collection, Manassas,
VA, USA) were grown in Dulbecco’s modified Eagle’s me-
dium (Gibco, Grand Island, NY, USA) containing 10% fetal
bovine serum (Gibco), and were used for amplifying the
viruses.
RNA extraction and sequencing
Total RNA was extracted from a viral supernatant using
TRIzol LS (Invitrogen, Grand Island, NY, USA); the extraction
was conducted according to the manufacturer’s protocol.
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DNA using SuperScript III reverse transcriptase (Invitrogen).
Polymerase chain reaction (PCR) was performed using a
proofreading DNA polymerase (KOD-Plus, Toyobo, Osaka,
Japan). The primers used are listed in Supplementary Table
S1 (see Appendix A for a full index of supplementary data).
In this study, the general PCR conditions included 32 cycles
of 94C for 30 seconds, 58e62C for 30 seconds, and 68C
for 2 minutes. Each PCR fragment was gel extracted and
purified before being sequenced using the respective PCR
primers.
The nucleotide sequence data reported in this study
were deposited in the GenBank nucleotide sequence data-
base (KR733244eKR733276 for the HA sequences and
KR733211eKR733243 for the NA sequences; see Table S2).
Sequence data
In addition to the 33 HA sequences obtained for this study,
all Taiwanese HA1 sequences containing at least
238e939 nt were downloaded from the National Center for
Biotechnology Information (http://www.ncbi.nlm.nih.gov/
genomes/FLU/) and Global Initiative on Sharing Avian
Influenza Data (http://platform.gisaid.org/) databases on
July 5, 2015 (Table S3). This genomic region is known to
contain an HA head domain prone to frequent mutations to
evade the binding of protective antibodies against influenza
viruses.18 In this study, an influenza season was defined as
from October 1 to May 31 of the next year. Sequences only
labeled with the year of isolation or which were isolated
between June 1 and September 30 were excluded to limit
the study focus to the genetic diversity and evolution of
influenza B seasonality in Taiwan. A total of 222 sequences
of HA1 sampled between October 1, 2003, and May 31,
2014, were analyzed (see Table S3).
Phylogenetic analysis
Multiple sequence alignments were constructed using Bio-
Edit version 7.2.5 (http://www.mbio.ncsu.edu/bioedit/
bioedit.html) with the default settings.19 A rooted phylo-
genetic tree was developed by incorporating a temporal
scale to explore the dynamics of influenza B viruses in
Taiwan. Bayesian Evolutionary Analysis by Sampling Trees
(BEAST) version 1.8.0 was used to calculate a phylogeny
using the date constrains of the isolates, under the SRD06
codon position and the HasegawaeKishinoeYano substitu-
tion model, assuming a constant population size, and using
a strict molecular clock rate model.20e22 The length of the
Markov chain Monte Carlo chain was set to 10,000,000
generations; the initial 10% of the chains were discarded as
burn-in. The resulting trees were summarized in TreeAn-
notator version 1.8.0 using the maximum clade credibility
(MCC) criterion, and were visualized using FigTree version
1.4.2.
Selection pressures
The selection pressures at codon sites were analyzed using
single likelihood ancestor counting (SLAC), fixed effects
likelihood (FEL), and random effects likelihood (REL)algorithms included in the HyPhy package, accessed
through the Datamonkey website (http://www.
datamonkey.org).23,24Results
Time-scaled phylogenetic tree for HA1 genes of
influenza B viruses
A total of 222 Taiwanese HA1 sequences and two pro-
totypes, namely, B/Victoria/02/87 and B/Yamagata/16/88,
were used to produce a time-scaled phylogenetic tree
based on the MCC algorithm in BEAST version 1.8.0. There
were 133 Taiwanese HA1 sequences belonging to the
Yamagata lineage and 89 to the Victoria lineage (Figure 1).
These viruses were contemporaneous but independently
evolved in Taiwan. The strains of the Victoria lineage were
shown in a directional manner; the contemporary viruses
generally evolved from their predecessors in a single cluster
of ladder-like branches. The most recent members in the
Victoria lineage, the 2013/2014 strains, were easily found
at the top-right corner of this cluster away from the root.
In contrast to the Victoria lineage strains, those of the
Yamagata lineage showed a more complex tree topology.
Many were interlaced across multiple clades that appeared
to have evolved independently over time. For example, the
strains from the 2003/2004 season (in yellow in Figure 1)
were individually found in two separate clades: six viruses
(labeled “2003/04 I”) belonged to Clade I.a and six viruses
(labeled “2003/04 II”) belonged to Clade II.b. Viruses from
the 2004/2005 season (in orange) were mostly found in
Clade I.b (15 Taiwanese strains labeled “2004/05 I”), with
one (B/Taiwan/142/2005) in Clade II.b and four (labeled
“2004/05 II”) in Clade II.d. Only one Yamagata-like virus
(B/Taiwan/2/2006 in pink) was found in Clade I after the
2004/2005 season (found in 2005/2006). In fact, the num-
ber of Yamagata-like viruses observed in Taiwan was low
during both the 2005/2006 season (1 in Clade I.b and 1 in
Clade II.d; in pink) and the 2006/2007 season (2 in Clade
II.d; in red), particularly when compared with the 6 and 19
Victoria-like viruses found during the 2005/2006 and 2006/
2007 seasons, respectively.
The Taiwanese Yamagata-like viruses for the 2007/2008
(light blue) and 2008/2009 (dark blue) seasons were more
prominent than the Victoria-like ones. The Yamagata-like
viruses were distributed in Clades II.a, II.c, and II.d. By
contrast, the Taiwanese viruses in the 2010/2011 season
(light green) were found to belong to both lineages equally
(7 in Yamagata and 8 in Victoria); 61 of 68 Taiwanese viruses
were Yamagata-like in the 2011/2012 season (gray), and
were clustered in Clade II.d. Moreover, most of the viruses
from the final two seasons were found in Clade II.c. This
reflects the complex and dynamic evolution of Yamagata-
like viruses in Taiwan.
Cocirculation of the Yamagata- and Victoria-like
viruses
Figure 2 summarizes the statistics of the viruses partici-
pating in Figure 1. In Taiwan, the two lineages were found
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Figure 1 Phylogenetic relationship of influenza B virus HA1 genes in Taiwan from 2003 to 2014. The time-scaled Bayesian
maximum clade credibility tree was inferred for the 222 HA1 sequences sampled in each season between 2003 and 2014. The
branches and strains are colored according to their respective season, as illustrated in the upper left panel. Horizontal branch
lengths are drawn to scale, with the bottom bar indicating the years. The tree was automatically rooted under the assumption of a
relaxed molecular clock. Vic Z Victoria lineage; Yam Z Yamagata lineage.
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Figure 2 Lineage-specific statistics for influenza B viruses that circulated in Taiwan during 2003e2014. (A) Partitioning of
Yamagata- (filled white) and Victoria-specific (filled black) Taiwanese strains for each influenza season (October 1 to May 31 of the
next year); (B) vaccine strains with their respective lineage attributed to influenza B virus recommended by the World Health
Organization for use in trivalent vaccines in the Northern Hemisphere.
514 S.-M. Kuo et al.to be cocirculating in every season from 2003 to 2014. The
trivalent vaccine was recommended by the WHO for sea-
sonal influenza in every study year. The vaccine strains for
influenza B viruses are depicted in Figure 2 according to the
lineage (Yamagata or Victoria) of their HA sequences. For
example, B/Hong Kong/330/2001 of the Victoria lineage
was recommended as the vaccine strain for the 2003/2004
season. However, in the same season, only one HA1
sequence was classified as Victoria-like, whereas the other
12 were identified as Yamagata-like (see Table S4). This
indicates that the 2003/2004 season was dominated by
Yamagata-like isolates, which suggests that the widely
received Victoria-like vaccine strain was effective in
limiting the spread of Victoria-like viruses.
In some seasons, however, the lineage of the dominant
sequences matched the lineage of the vaccine strain
selected in the same season. These are highlighted in
Figure 2. One example was in the 2006/2007 and 2009/2010
seasons, when a Victoria-like B/Malaysia/2506/2004 strain
and a B/Brisbane/60/2008 strain were selected as the
vaccine strains, respectively. The statistics for the Taiwa-
nese sequences investigated in this study revealed that 19
of the 21 sequences in the 2006/2007 season and 19 of the
23 sequences in the 2009/2010 season were Victoria-like.
Moreover, 10 of the 11 HA1 sequences in the 2008/2009
season were Yamagata-like, although the B/Florida/4/2006
vaccine strain of the Yamagata lineage had been used.
Table S4 presents the sequence count statistics. These re-
sults suggest that the circulated Taiwanese strains might
have genetically evolved to deviate from their corre-
sponding vaccine strains.Mutations occurred in the neutralizing epitopes
and glycosylation sites of HA sequences
We also investigated the HA1 sequences from each of the
three highlighted seasons exhibiting circulating influenza B
viruses that matched the lineage of the corresponding
vaccine strain. Figure 3A illustrates the partial alignment of
16 Victoria-like Taiwanese sequences in the 2006/2007
season, along with the corresponding Victoria-like vaccine
strain sitting at the top. The alignment of the three
Victoria-like Taiwanese sequences was excluded from
Figure 3A because they contained ambiguous nucleotides,
resulting in invalid amino acids in the glycosylation sites
that we had intended to present (data not shown).
Compared with the Victoria-like vaccine strain B/Malaysia/
2506/2004 implemented in the same season, six sub-
stitutions were observed at position 212, and 13 sub-
stitutions were observed at position 214 in the glycosylation
site. Similar amino acid substitutions are indicated in
Figures 3B and 3C in this glycosylation region. The 10 se-
quences included in Figure 3B (2008/2009 season) belonged
to the Yamagata lineage, whereas the sequences in Figures
3A and 3C belonged to the Victoria lineage. As a result,
Figure 3B revealed one D211N substitution at the glycosyl-
ation site (corresponding to position 212 in the Victoria-like
strains) caused by a characteristic deletion on the N-ter-
minal HA1 for the Yamagata-like strains. Remarkably, no
substitution was observed at position 213 (as seen in posi-
tion 214 of the Victoria-like Taiwanese strains in Figures 3A
and 3C) for these Yamagata-like Taiwanese sequences.
Figure 3 Mutations in the neutralizing epitopes and glycosylation sites. Multiple sequence alignments of hemagglutinin (HA)
proteins displaying high incidence of lineage-specific strains that matched vaccine strain lineages (Figure 2) in the (A) 2006/2007,
(B) 2008/2009, and (C) 2009/2010 seasons. N180Y is in the neutralizing loop epitope; D211N for the Yamagata-like strains (2008/
2009 season); and N212S/D/I and I214T/A/N (2006/2007 season) and N212/G/K/S and T214A/N (2009/2010 season) for the Victoria-
like strains are in the glycosylation sites.
Influenza B viruses circulated in Taiwan 515Glycosylation is a crucial mechanism of the immune evasion
strategy by influenza virus.25e27 A loss of glycosylation at
HA 212 would consequently add the capacity to bind to a-
2,3 in addition to a-2,6-linked sialic acid host receptors,27
which may reduce the cross-protection from the induced
antibody.Although Figure 3 indicates the mutations at the glyco-
sylation site in relation to the corresponding vaccine
strains, Figures 3A and 3C of the Victoria-like sequences
reveal HA 212N mutating into mostly S among others (D, I,
G, or K); in Figure 3B, the same glycosylation site (HA 211 in
terms of Yamagata coordinates) was found mutating from D
516 S.-M. Kuo et al.in the vaccine strain B/Florida/4/2006 to N in all 10
Taiwanese strains. Figure 3B additionally showed a substi-
tution N180Y in the HA loop epitope, reportedly the main
neutralizing epitope for the Yamagata-like influenza B vi-
ruses.28,29 Our results indicate that amino acid substitutions
occurred in the HA loop epitope, and that the glycosylation
site may be involved in immune escape, leading to the
spreading of lineage-specific influenza B viruses from a
vaccine of the same lineage strain.
HA sequences for influenza B epidemics in China and
Japan were also analyzed for the correlation between
circulating pattern and HA amino acid substitutions. Details
for HA sequences investigated are presented in Tables S5
and S6. Similar to what was observed in Taiwan for the
season 2009/2010, where the Victoria-like virus was the
epidemic virus despite a Victoria-like vaccine strain B/
Brisbane/60/2008 being used, in China 44 of 66 (or 66.7%)
viruses were Victoria-like (see Supplementary Fig. S1). In
the previous 2008/2009 season when a Yamagata-like vac-
cine strain B/Florida/4/2006 was recommended, Taiwanese
strains were dominated by Yamagata-like viruses. In China
and Japan, however, the epidemic virus went the other way
to be Victoria-like for the same season (see Figs. S1 and S2).
Another inconsistent pattern was seen for the seasons
2012/2013 and 2013/2014 when the two Yamagata-like
vaccine strains B/Wisconsin/1/2010 and B/Massachusetts/
2/2012 were both administered; however, in this case
Taiwan encountered less Yamagata-like viruses (6 of 19, or
31.6%) as expected, whereas China and Japan saw more (31
of 44, or 70.5% in China, and 192 of 333, or 57.7% in Japan).
Following the same procedure as for Figure 2, the
dominant sequences with lineage matching the lineage of
the vaccine strain are highlighted in Figures S1 and S2 for
Chinese and Japanese influenza B viruses, respectively. Two
seasonsd2004/2005 and 2013/2014din China were found
to be dominated by Yamagata-like viruses, although
Yamagata-like vaccine strains were implemented in both
seasons (see Figure S1). Figure S3 additionally shows the
multiple sequence alignments for the 19 Yamagata-like HA
proteins that dominated in the 2004/2005 season (see
Figure S3A) and the 23 Yamagata-like viruses that domi-
nated in the 2013/2014 season (see Figure S3B) in China.
Amino acid substitutions were found in these Yamagata-like
viruses in either the loop epitope or the glycosylation site,
similar to what were observed for Taiwanese strains in
Figure 3. Although the circulating patterns were not
temporally aligned based on the data derived from Taiwan
(Figure 2) and China (see Figure. S1), we did notice the
mutations that occurred in either the loop epitope or
glycosylation sites in these seasons in China, which were in
line with the observation in Taiwan, that is, the spreading
of an endemic influenza B lineage that matched with the
vaccine strain lineage.
By contrast, two seasonsd2009/2010 and 2010/
2011dwere found to be dominated by Victoria-like viruses
with a Victoria-like vaccine strain implemented in both
seasons in Japan (see Figure. S2). In Figures S4 and S5, each
representing the HA alignment for these endemic Victoria-
like viruses, only limited mutations were observed in either
the neutralizing epitopes or the glycosylation sites. How-
ever, this is different from the observations in Taiwan and
China.HA amino acids under positive selection for
influenza B viruses
We further investigated how mutations in these Taiwanese
HA sequences could lead to an advantage for adaptation.
The previously used 222 HA sequences were trimmed to 100
full-length HA sequences before being examined for adap-
tive selection. These 100 HA sequences spanned from
February 2004 to April 2014 (see Table S7). Two positively
selected sites, amino acid (aa) 212 and 214, were identified
in both the SLAC and FEL models (p < 0.05, first row of
Table 1). The result was in line with the variations pre-
sented at the glycosylation sites (Figure 3), suggesting that
mutations in the glycosylation sites could facilitate the
adaption of influenza B viruses in Taiwan. However, the REL
analysis could not be performed on the 100 full-length HA
sequences because of the alignment size restriction of the
software website.
To assess how HA 212 and 214 (211 and 213 for the
Yamagata-like viruses) were under positive selection for
each of the two subpopulations, 54 Yamagata-like (second
row, Table 1) and 46 Victoria-like HA sequences (third row,
Table 1) were separately examined. Although aa 212
(p < 0.05 for FEL) and 214 (p < 0.05 for both SLAC and FEL,
and posterior probability > 0.99 for REL) were still assessed
to be under positive selection for these 46 Victoria-like
viruses, neither of the two positions was predicted for
adaptive selection of the 54 Yamagata-like viruses. These
observations prompted different selection advantages for
the aforementioned glycosylation sites between the two
influenza B lineages in Taiwan between 2004 and 2014.
In comparison, we investigated 245 full-length HA se-
quences between 2004 and 2014 from China using the
same algorithms (see Table S8). Both SLAC and FEL showed
that 127 Victoria-like sequences have positions 212 and
214 as positively selected sites (p < 0.05). Among the 118
Yamagata-like sequences, only FEL suggested position 211
(same as position 212 for Victoria-like viruses) as a posi-
tively selected site (p < 0.05). A large-scale analysis over
900 influenza B genomes isolated between 2002 and 2013
from Australia and New Zealand also showed Victoria HA
212 and 214 to have experienced positive selection,
whereas none in the Yamagata lineage.30 These results
suggest that the two sites 212 and 214 of Victoria HA se-
quences from Taiwan, China, and Australia/New Zealand30
have been indeed experiencing positive selection in the
past decade. By contrast, an analysis of all available 373
full-length HA sequences from Japan predicted neither
position 212 nor position 214 as positively selected sites. It
is mentioned that these full-length Japanese HA se-
quences spanned the years 2007e2014, with most
appearing only in the recent three seasons (367 of 373
sequences).
No drug-resistant variations in NA of influenza B
viruses
Influenza NA is a surface protein that enables the virus to
be released from the infected host cells. Using inhibitors to
block the cleavage function of influenza NA is an effective
means of treating the disease. Many NA inhibitors have
Table 1 List of amino acids of Taiwan (TW) HA of influenza B viruses under positive selection inferred by each algorithm.
Model SLAC analysis FEL analysis REL analysis
Full-length HA Positively
selected sites (aa)
Normalized (p) Positively
selected
sites (aa)
Normalized dN/dS (p) Positively
selected
sites (aa)
Normalized dN/dS
(posterior probability)
TW (n Z 100) 212 * 5.838 (0.049) 212 * 15.323 (0.006) N/A a
214 * 14.636 (0.001) 214 * 35.387 (0.001)
Yamagata TW b
(n Z 54)
211 2.590 (0.498) 211 16.230 (0.192) 211 16.23 (0.192)
213 9.684 (0.101) 213 47.207 (0.105) 213 3.901 (0.999)
Victoria TW
(n Z 46)
212 8.832 (0.146) 212 * 85.464 (0.034) 212 15.635 (0.985)
214 * 21.639 (0.004) 214 * 206.593 (0.001) 214 * 15.876 (>0.99)
FEL Z fixed effects likelihood; HA Z hemagglutinin; REL Z random effects likelihood; SLAC Z single likelihood ancestor counting.
* p < 0.05 of SLAC and FEL, and posterior probability > 0.99 of REL for statistical significance suggested that one site is under positive
selection.
a This analysis could not be performed because of an alignment size restriction.
b One amino acid difference in the length of HA proteins between two lineages.
Influenza B viruses circulated in Taiwan 517been introduced for clinical use; however, drug-resistant
NA amino acids have been reported, such as the
oseltamivir-resistant mutations E105K,31 G109E,32
E119A,33,34 D197E,35 D198N,36,37 I221V,38 I222T,36
H274Y,34,39 R292K,34 and N294S40; zanamivir-resistant mu-
tations G109E,32 E119A,33,34 R152 K,34 D197E,35,37 and
I222T36; and peramivir-resistant mutations E105K,31
D197E,35 and H273Y(H274Y).41 We examined the drug
resistance of all 100 Taiwanese full-length NA sequences
available from databases, as well as those obtained in this
study. These 100 HA sequences spanned from February 2004
to April 2014. We observed no amino acid substitution
leading to drug resistance, suggesting that NA inhibitors
may still be suitable as a first-line treatment of influenza B
infections in Taiwan.Occurrence of NA reassortment in several influenza
B viruses
Influenza viruses with segmented genomes are known to
exhibit genetic shift through gene reassortment. Between
2004 and 2014, 100 Taiwanese strains with their full-length
HA and NA sequences (including the 33 from this study, as
listed in Table S7) were used to construct the HA and NA
phylogenetic trees to determine possible NA reassortment
(Figure 4). Two prototype strains, one for Yamagata and
one for Victoria, as well as the vaccine strains recom-
mended by the WHO were also included in the trees for
reference. The HA sequences diverged into distinct Yama-
gata and Victoria lineages, similar to that observed in
Figure 1. Although classification of the two lineages was
solely based on HA sequences, it is clear that most NA se-
quences also naturally came under lineage-specific clades
in Figure 4B, with their lineage identified according to the
vaccine strains clustered with them. For example, Clades I
and II were labeled Yamagata-like because Yamagata-like
vaccine strains were embedded within these clades. Simi-
larly, Clades III and IV were labeled Victoria-like for the
same reason.
Among the analyzed Taiwanese strains, six (see
numbered arrowheads in Clades III and IV in Figure 4B) were
classified as Yamagata-like in Figure 4A. For example, B/Taiwan/00202/2011 was labeled Number 3 within the
Yamagata lineage in Figure 4A. In Figure 4B, however, it
was clustered within the Victoria-like Clade III, with the
Victoria-like vaccine strain B/Brisbane/60/2008 in prox-
imity. The other reassorted NA genes were B/Taiwan/
72168/2004, B/Taiwan/71909/2007, B/Taiwan/00507/
2008, B/Taiwan/00482/2013, and B/Taiwan/00252/2014.
The overall incidence rate of NA reassortment for the
investigated Taiwanese strains was 6.0%.Discussion
In every study year, the WHO recommended that the
trivalent vaccine include one influenza A H1N1 strain, one
influenza A H3N2 strain, and one influenza B strain of either
the Yamagata or Victoria lineage. The recommendation for
the Northern Hemisphere was made during the spring of
each year according to the influenza epidemiology sum-
marized from the previous season. Because of the distinct
antigenic properties exhibited in the two influenza B line-
ages, the lineage mismatch between the circulating influ-
enza B viruses and the vaccine strain led to unexpected
virus outbreaks. The geographic location of Taiwan makes it
a destination for traders and travelers year-round, which
promotes the transmission of various influenza virus strains.
As shown in Figures 1 and 2, the cocirculation of the two
influenza B lineages in Taiwan has been extensive. A
mismatch of lineage has promoted the viruses of the other
lineage to dominate. This is evident in the 2003/2004,
2007/2008, and 2011/2012 seasons from Figure 2, in which
the Victoria-like vaccines were selected and the Yamagata-
like viruses prevailed. In contrasting scenarios such as those
in the 2006/2007 and 2009/2010 seasons, Victoria lineage
viruses were found to have dominated despite Victoria-like
vaccines having been selected. The variations of biological
sequences are known to alter epitope structures, which in
turn affects the vaccine efficacy.42 The HA sequence anal-
ysis identified mutations at the glycosylation sites (212 and
214 for the Victoria lineage, and 211 for the Yamagata
lineage) as well as within the loop epitope (180 for the
Yamagata lineage). These mutations were found near the
host receptor-binding site (see Figure S6), suggesting their
Figure 4 Phylogenetic relationship of full-length hemagglutinin (HA) and neuraminidase (NA) of influenza B viruses isolated in Taiwan from 2004 to 2014. This figure shows the
time-scaled Bayesian maximum clade credibility tree of the full-length (A) HA and (B) NA genes. Table S7 lists the date, lineage (based on HA), and accession numbers for the
studied 100 Taiwanese strains. These 100 strains spanned from February 2004 to April 2014. Two prototypes each for Victoria and Yamagata lineages, as well as the vaccine strains
implemented in Taiwan, are included for reference. Strains exhibiting NA reassortment are accompanied by numbered arrowheads for clarity.
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520 S.-M. Kuo et al.involvement in antigenic changes leading to vaccination
ineffectiveness.
The circulating patterns of influenza B viruses in neigh-
boring countries China and Japan were also produced for
comparison. Both countries showed circulating patterns
(see Figures S1 and S2), which were not temporally aligned
with what were observed in Taiwan (Figure 2). We did
notice the emergence of amino acid substitutions at either
the loop epitope or glycosylation sites in certain Chinese
seasons, and this might be responsible for an endemic of
one particular lineage to occur despite the fact that the
vaccine strain was also of the same lineage. In Japan,
however, only limited mutations were observed in either
the neutralizing epitopes or the glycosylation sites in those
seasons displaying an endemic virus matching with the
vaccine lineage. This is different from what were observed
in Taiwan (Figure 3) and in China (see Figure S2). Whether
the association of the emergence of one particular
epidemic virus with what vaccine was used could be
attributed to the substitutions at either loop epitope or
glycosylation sites remains to be investigated.
Two positively selected sites, HA 212 and 214, of Victoria
HA sequences from Taiwan (Table 1), China (see Table S8),
and Australia/New Zealand30 have been experiencing pos-
itive selection and evolving under similar adaptive selection
forces in the past decade. On the other hand, upon the
available 373 full-length HA sequences between 2007 and
2014 from Japan, neither position 212 nor position 214 was
detected as positively selected sites. We mentioned that
these full-length HA sequences of Japan were mostly
appearing only in the recent three seasons. As a result,
selection analysis of this short-term Japanese population
may not yield satisfactory results as we observed from the
decade-long samples of Taiwan, China, and Australia/New
Zealand.30 Nevertheless, mechanisms possibly involving
other adaptive selection in Japan should not be ruled out
upon future investigation.
In contrast to the investigated Taiwanese Victoria-like
HA sequences, which formed a ladder-like tree branch, the
HA of the Taiwanese Yamagata-like viruses were clustered
into several clades and subclades (Figure 1). This enables
the Yamagata-like viruses to evolve in multiple dimensions.
Not only could new taxa grow within any of the existing
clades in a monophyletic manner, but also the Yamagata-
like viruses may often grow in multiple clades in a poly-
phyletic or paraphyletic fashion. For example, viruses from
the 2004/2005 season were observed in Clades I.b, II.b, and
II.d (labeled in orange in Figure 1). This illustrated that not
only viruses of the two lineages cocirculated, but also vi-
ruses of the same Yamagata-like lineage but different
sublineage could emerge simultaneously. This is also true in
Victoria-like HA sequences. For example, one 2008 virus (B/
Taiwan/48/2008) was found clustering with most viruses
from 2004/2005 to 2005/2006, and a couple of 2009 and
2011 viruses appeared together with viruses from the 2006/
2007 seasons. The mixing of viruses from neighboring sea-
sons, however, is less seen in Victoria-like viruses rather
than in Yamagata-like viruses.
One feature that the Yamagata lineage has in evolving is
that it may be absent in some of these sublineages. For
example, in Clade I in Figure 1, the most recent taxa were
found to be from the 2005/2006 season. Similarly, Clade II.dwas updated up to only 2011/2012 viruses. Viruses from the
final two study seasons (2012/2013 and 2013/2014) were
added to Clade II.c, although the numbers were far lower
than those of the previous 2011/2012 season for the same
clade.
The distinct evolutionary patterns observed between the
Yamagata and Victoria lineages in Figure 1 could also be
associated with adaptive selection. Table 1 lists both the
HA 212 and 214 positively selected sites for the 46 partici-
pating Victoria-like viruses. However, no positive selection
site was inferred from the 54 analyzed Yamagata-like HAs.
Therefore, it can be concluded that the two lineages of
influenza B viruses cocirculating in Taiwan were each under
different adaptive selection forces. The positive selection
in Victoria viruses may play a critical role in the accumu-
lation of point mutations, thus shaping the phylogenetic
tree into the observed ladder-like manner. Furthermore,
the complex topologies observed in the Yamagata lineage
could be related to the lack of positive selection. These
areas could be researched in future studies.
Finally, although no drug-resistant sites were found in
Taiwanese NA sequences between 2004 and 2014, we found
that 6 of the 100 analyzed NA sequences were reassorted.
Three lineages of influenza B virusesdB/Shanghai/361/
2002-like (Yamagata lineage), B/Hong Kong/330/01-like
(Victoria lineage), and the B/Hong Kong/1351/02-like
strain (reassorted with Victoria-like and Yamagata-like
HA)dwere already cocirculating in 2002 in Taiwan.43 Pre-
viously, we analyzed Taiwanese influenza B viral genomes
and found that two international strainsdB/Oslo/71/04
and B/England/23/04dwere consistently clustered
together with the six putative reassortants isolated in
Taiwan in 2004 and 2005.15 This suggests that the Taiwa-
nese reassortants might have also been imported rather
than being mixed from local Taiwanese strains. The six vi-
ruses we noticed showing reassortment were from the years
2004, 2007, 2008, 2011, 2013, and 2014, which could be the
descendants from the aforementioned reassortants, either
locally mixed or putative imports from other geographical
regions. The frequent international traders and travelers
would certainly play an important role for the emergence
of these reassortments. NA reassortment may alter the
compatibility of the two surface genes, thus leading to the
development of a novel influenza B virus. Our results
highlight the interplay between mutations in the glycosyl-
ation sites, epitope, and receptor-binding sites in HA evo-
lution and NA reassortment. These are crucial molecular
signatures to be monitored for influenza B epidemics in
Taiwan in the future.Acknowledgments
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